Medifast MED Optavia Segment — Cost of Sales
Similar metrics at other companies
Other financials
Where this comes from
Reported directly by Medifast in its filing.
Tagged under the XBRL concept us-gaap:CostOfRevenue.
The official record: Medifast’s 10-Q, filed May 4, 2026, on SEC EDGAR. View the filing →
Ask your AI about Medifast's optavia segment — cost of sales.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Medifast's optavia segment — cost of sales?
- Medifast (MED) reported optavia segment — cost of sales of $24.29M in Q1 2026.
- How has Medifast's optavia segment — cost of sales changed year-over-year?
- Medifast's optavia segment — cost of sales decreased by 22.9% year-over-year, from $31.48M to $24.29M.
- What is the long-term trend for Medifast's optavia segment — cost of sales?
- Over 3 years (2022 to 2025), Medifast's optavia segment — cost of sales has grown at a -37.7% compound annual growth rate (CAGR), from $458.16M to $110.6M.
- What does optavia segment — cost of sales mean?
- Includes the direct costs attributable to the production and procurement of nutritional products sold within the Optavia segment. Monitoring this metric is essential for evaluating manufacturing efficiency and the impact of raw material price fluctuations on gross margins.